Ronald Dean Cummings v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2019)
Case summary [AI summaries can sometimes make mistakes]
Ronald Dean Cummings filed a petition for vaccine compensation on November 17, 2017, alleging that he suffered Guillain-Barre Syndrome (GBS) as a result of an influenza vaccine he received on September 23, 2016. The respondent denied that Mr.
Cummings sustained a Table GBS injury or any injury from the vaccine. Despite these positions, the parties filed a joint stipulation on September 26, 2019, agreeing to settle the case and award compensation.
The Special Master adopted the stipulation, awarding Mr. Cummings a lump sum of $97,000.00 for all damages.
This amount represents compensation for all items of damages available under the Vaccine Act. The case was settled as a Table claim, and the parties released all claims related to the alleged vaccine injury.
Petitioner was represented by Temple Witt Cabell of Cabell Law Firm, P.C., and the respondent was represented by Robert Paul Coleman, III of the U.S. Department of Justice.
The decision was issued by Chief Special Master Nora Beth Dorsey.
Theory of causation
Petitioner Ronald Dean Cummings received an influenza vaccine on September 23, 2016, and alleged he suffered Guillain-Barre Syndrome (GBS) as a result. Respondent denied a Table GBS injury or any injury from the vaccine. The parties filed a joint stipulation agreeing to settle the case. The Special Master adopted the stipulation, awarding a lump sum of $97,000.00 for all damages. The case was settled as a Table claim. Petitioner was represented by Temple Witt Cabell, and respondent was represented by Robert Paul Coleman, III. Chief Special Master Nora Beth Dorsey issued the decision on November 1, 2019. The public decision does not describe the specific mechanism of injury, expert testimony, or detailed clinical facts regarding the onset, symptoms, tests, or treatments.
Source PDFs
USCOURTS-cofc-1_17-vv-01807